Cafepharma Today

AstraZeneca’s tremelimumab does not perform well in NSCLC trial
Does AstraZeneca pay its CEO too much?
The latest on Brexit and the pharma industry
Boston Scientific plans $200M restructuring
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

Current News

Biopharma Dive
Wednesday, November 14, 2018 - 11:45pm
BioSpace
Wednesday, November 14, 2018 - 11:42pm
Fierce Biotech
Wednesday, November 14, 2018 - 4:50pm
Motley Fool
Wednesday, November 14, 2018 - 4:42pm
tags:
Endpoints
Wednesday, November 14, 2018 - 4:41pm
tags:
Medical Design and Outsourcing
Wednesday, November 14, 2018 - 4:40pm
tags:
Biopharma Dive
Wednesday, November 14, 2018 - 4:39pm
Biopharma Dive
Wednesday, November 14, 2018 - 4:36pm

Pages

Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Breaking Healthcare News - powered by Seeking Alpha

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.